Abstract
AbstractThis research aimed to estimate whether first-time anxiety diagnoses and medication usage during and after the COVID-19 pandemic differed from diagnosis and medication usage rates prior to the COVID-19 pandemic, within groups stratified by age. We observed a significant increase in first-time anxiety diagnoses and prescriptions for 12–17-year-olds during April 2020-March 2021 compared to January 2018-February 2020. These trends were not sustained in subsequent periods. We also observed an increase in first-time prescriptions for 18–29-year-olds during the same time. The study emphasizes the importance of addressing mental health concerns, particularly among adolescents, both during and beyond the pandemic.
Publisher
Cold Spring Harbor Laboratory
Reference18 articles.
1. Racial inequality in COVID-treatment and in-hospital length of stay in the US over time
2. Adolescence and mental health
3. Centers for Disease Control and Prevention. (2022, March 31). New CDC data illuminate youth mental health threats during the COVID-19 pandemic. https://www.cdc.gov/media/releases/2022/p0331-youth-mental-health-covid-19.html
4. A Second Pandemic: Mental Health Spillover From the Novel Coronavirus (COVID-19)